Article: NAD+ Precursors Restore Mitochondrial Function and Prevent Nerve Damage in Diabetes: Preclinical Findings

PrevNext
Diabetes Metabolic Health Neurological Health Neuropathy Preclinical

NAD+ Precursors Restore Mitochondrial Function and Prevent Nerve Damage in Diabetes: Preclinical Findings

Synopsis

Diabetic peripheral neuropathy involves nerve degeneration linked to low NAD+ levels. Researchers tested whether NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) could prevent neuropathy in mouse and rat diabetes models. Treatment improved nerve function, prevented nerve fiber loss, and restored mitochondrial capacity in nerve cells, without affecting blood sugar or insulin. This suggests boosting NAD+ in nerves may be enough to protect against diabetic neuropathy.

Journal

International Journal of Molecular Sciences

Share

Read more

Metabolic Health

DNA Replication Stress Causes Complex Metabolic Changes: Preclinical Findings

SynopsisDNA replication stress occurs when cells struggle to copy damaged DNA, affecting metabolism. Using mice lacking the DNA polymerase Rev1, researchers observed sex-specific metabolic changes:...

Read more
Inflammation

Nicotinamide Riboside Helps Prevent Obesity, Inflammation, and Fibrosis: Preclinical Findings

SynopsisNR supplementation was tested in young and old obese female mice to see if it reduces liver inflammation and fibrosis. In old mice, NR decreased weight gain, fat mass, and improved glucose ...

Read more